Incyte

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Incyte and other ETFs, options, and stocks.

About INCY

Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. It focuses on hematology and oncology, and inflammation and autoimmunity therapeutic areas.

CEO

William J. Meury

CEOWilliam J. Meury

Employees

2,617

Employees2,617

Headquarters

Wilmington, Delaware

HeadquartersWilmington, Delaware

Founded

1991

Founded1991

Employees

2,617

Employees2,617

INCY Key Statistics

Market cap

13.25B

Market cap13.25B

Price-Earnings ratio

210.92

Price-Earnings ratio210.92

Dividend yield

—

Dividend yield—

Average volume

1.95M

Average volume1.95M

High today

$69.06

High today$69.06

Low today

$67.88

Low today$67.88

Open price

$68.08

Open price$68.08

Volume

1.27M

Volume1.27M

52 Week high

$83.95

52 Week high$83.95

52 Week low

$53.56

52 Week low$53.56

INCY News

TipRanks 10h

Incyte’s Phase 1 Study on INCB057643: A Potential Game-Changer for Myelofibrosis Treatment?

Incyte Corporation (($CC:INCY.CUR)) announced an update on their ongoing clinical study. Don’t Miss TipRanks’ Half-Year Sale Take advantage of TipRanks Premiu...

Analyst ratings

48%

of 29 ratings

Buy

48.3%

Hold

48.3%

Sell

3.4%

People also own

Based on the portfolios of people who own INCY. This list is generated using Robinhood data, and it’s not a recommendation.